Cardiac Arrhythmia Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and Arrhythmia Clinic, Lund University, Skåne University Hospital, Lund, Sweden.
Cardiac Arrhythmia Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and
J Nucl Med. 2015 Jun;56 Suppl 4:59S-64S. doi: 10.2967/jnumed.114.148452.
Heart failure is often complicated by arrhythmias that can adversely affect the quality of life and increase the risk for sudden cardiac death. Current risk stratification strategies for sudden cardiac death in the heart failure patient are not ideal, with much potential for further refinement. Overactivation of the sympathetic nervous system has been shown to be associated with worsening heart failure as well as arrhythmic events. Recent advances in our understanding of the autonomic nervous system and new methods for quantification of the pathologic activation of the sympathetic nerves have triggered increasing interest in this field. This viewpoint focuses on the need for and challenges of risk stratification of sudden death in the heart failure patient and discusses the potential value of measuring sympathetic nervous system activity to better stratify risk and to select patients with heart failure for implantable cardioverter defibrillator therapy.
心力衰竭常伴有心律失常,这可能会降低生活质量,增加心源性猝死的风险。目前心力衰竭患者心源性猝死的风险分层策略并不理想,还有很大的改进空间。交感神经系统的过度激活已被证明与心力衰竭恶化以及心律失常事件有关。我们对自主神经系统的理解的最新进展以及量化交感神经病理性激活的新方法引发了人们对这一领域的浓厚兴趣。本文观点聚焦于心力衰竭患者心源性猝死风险分层的必要性和挑战,并探讨了测量交感神经系统活性以更好地分层风险和选择心力衰竭患者进行植入式心脏复律除颤器治疗的潜在价值。